Titled “The New Biotech Cold War: The U.S. Medicine Can’t Afford to Fall Behind China,” the report shows how U.S. biotech – long a pillar of national strength – no longer has a guaranteed edge globally.
The Trump administration’s Section 232 investigation into pharmaceutical imports is reportedly close to being final. The final investigation’s success will depend largely on whether or not the Commerce Department determines that there is a crisis in the generics industry — an issue that President Trump highlighted back in 2023.
Strong enforcement against trade fraud isn’t optional—it’s essential to rebuilding our industrial base and securing long-term prosperity for American communities.
The U.S. Shipbuilding Base has Withered Since the 80s; Latest CPA Report Examines What’s Needed to Bring it Back
The August 2025 inflation report has reignited debate over tariffs. Some pundits have been quick to blame trade policy for rising prices, invoking Smoot-Hawley comparisons and warning of disaster on the scale of the Great Depression. But the data tells a different story.
The latest Section 232 announcements expand the list of ongoing investigations into imported goods that could be exposed to higher tariffs.
As proof that no company can match China on price, Chinese producers of active pharmaceutical ingredients (APIs) and the key starting materials (KSMs) used to make them are slashing prices by up to 50%. Not even low-cost India – one of the largest importers of Chinese KSMs – can compete at those levels.
Data centers powering AI need copper wiring and transformers. EVs use nearly four times more copper than gas-powered cars. Wind turbines, solar farms and the modern electric grid all depend on it. As such, copper is a building block of tomorrow’s economy and the backbone of America’s national security.
For the second time in less than two months, the CEO of a publicly traded company admitted that tariff cost burdens will not be passed down fully, if at all, to consumers. With one CEO saying tariffs were too low.
The trade deficit rose 32.5% in July and imports were up 5.9%, but much of this can be attributed to importers bulking up on orders as the full brunt of the “Liberation Day” tariffs were set to start in August.
